Why scientists' failure to understand GM opposition is stifling debate and halting progress
By Sarah Hartley,
The Conversation
| 07. 07. 2016
Genetically modified crops are safe for human consumption and have the potential to feed the world and improve human health, scientists have been telling us for years. On June 30, 110 Nobel laureates from around the world signed a letter demanding that the environmental pressure group Greenpeace stop its campaign against GM crops. How many people must die before we consider this a “crime against humanity”? the letter asks.
The scientists are accusing Greenpeace of ignoring facts, misrepresenting risks and benefits, failing to recognise the authority of science and relying on emotion and dogma. They are particularly concerned about Greenpeace’s opposition to Golden Rice, which has an added gene that boosts vitamin A levels – something scientists claim is much needed in many poor populations.
But Greenpeace argues that there are cheaper and more effective alternatives to Golden Rice and that GM rice developers are out of touch with the needs of local populations. It also claims developers are downplaying the risk that GM rice will contaminate traditional and organic rice crops.
The eminent scientists appear to have learned...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...